Jan Dominik Haas

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Galapagos Nv, Morphosys Ag. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan Dominik Haas. Retrieved from https://idiyas.com/inventor/jan-dominik-haas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 2)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

München, DE (2019 - 2020)
Munich, DE (2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2019-2024

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11987621 - Antibodies for IL-17C (2024-05-21),

2. 10633439 - Antibodies for IL-17C (2020-04-28),

3. 10259869 - Antibodies for IL-17C (2019-04-16),

Title: Jan Dominik Haas: Innovator in Antibody Development

Introduction

Jan Dominik Haas is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 3 patents, Haas has focused on innovative solutions for treating various human conditions.

Latest Patents

One of his latest patents involves antibodies for IL-17C. This invention provides antibodies or antibody fragments that bind to human IL-17C. These antibodies have combined beneficial properties, making them useful for the treatment of conditions such as atopic dermatitis and psoriasis. This work highlights Haas's commitment to advancing medical treatments through innovative antibody design.

Career Highlights

Throughout his career, Jan Dominik Haas has worked with prominent companies in the biotechnology sector. He has been associated with Morphosys AG and Galapagos NV, where he has contributed to various research and development projects. His expertise in antibody technology has positioned him as a valuable asset in these organizations.

Collaborations

Haas has collaborated with several professionals in his field, including Jürgen Klattig and Nick Ernest René Vandeghinste. These collaborations have further enhanced his research and development efforts, leading to impactful innovations in antibody therapies.

Conclusion

Jan Dominik Haas is a distinguished inventor whose work in antibody development has the potential to transform treatments for various diseases. His innovative patents and collaborations reflect his dedication to advancing medical science.

Profile summary based on public USPTO records.